Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2017 Jun;52(6):926-928.
doi: 10.1038/bmt.2017.38. Epub 2017 Mar 13.

High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome-implication for the utility of serial biomarker monitoring

A T Nunes  1 , P Jain  2 , D E Kleiner  3 , N N Shah  4 , P Anandi  2 , F Chinian  2 , P Muranski  2 , M Battiwalla  2 , A J Barrett  2 , S Ito  2
Affiliations
Clinical Trial

High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome-implication for the utility of serial biomarker monitoring

A T Nunes et al. Bone Marrow Transplant. 2017 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors declare no conflict of interest.

Figures

Figure 1.
Figure 1.
Timeline of treatments and total bilirubin and corresponding plasma levels of biomarkers.
Figure 2.
Figure 2.
Pathology findings of liver biopsy (Case 2). (a) Sinusoidal dilation, (b) representative picture of occluded vein, (c) small occluded vein with new collagen deposition highlighted by Masson stain.
See this image and copyright information in PMC

References

    1. Richardson PG, Riches ML, Kernan NA, Brochstein JA, Mineishi S, Termuhlen AM et al. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure. Blood 2016; 127: 1656–1665. - PMC - PubMed
    1. Myers KC, Dandoy C, El-Bietar J, Davies SM, Jodele S. Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2015; 21: 379–381. - PMC - PubMed
    1. Kennedy-Nasser AA, Ku S, Castillo-Caro P, Hazrat Y, Wu MF, Liu H et al. Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity. Clin Cancer Res 2014; 20: 2215–2225. - PMC - PubMed
    1. Anandi P, Tian X, Chinian F, Cantilena CR, Dunavin N, Hensel N et al. Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system. Bone Marrow Transplant 2016; 51: 1615–1616. - PMC - PubMed
    1. Akil A, Zhang Q, Mumaw CL, Raiker N, Yu J, Velez de Mendizabal N et al. Biomarkers for diagnosis and prognosis of sinusoidal obstruction syndrome after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2015; 21: 1739–1745. - PMC - PubMed

Publication types